Latest Market Research Report 2025

  The global  medical specimen tracking system market  size is expected to reach USD 1,771.24 million by 2030, registering a CAGR of 10.5% from 2024 to 2030, according to a new report by Grand View Research, Inc. The key factors driving the market growth include the technological advancements by market players and increasing product adoption for reducing errors in patient diagnosis. Before the COVID-19 pandemic, the adoption of specimen tracking solutions was less. However, due to the pandemic, the demand for these systems skyrocketed, which positively influenced the market growth. Most market players, such as Labcorp Drug Development, Agilent Technologies, and Thermo Fisher Scientific, experienced positive growth from 2019 to 2020 in their segment-specific revenues as well as annual revenues.   For instance, Labcorp Drug Development experienced 21% growth and Thermo Fisher Scientific experienced 26.1% growth from 2019 to 2020. On the other hand, Zebra Technolog...

  Medical Specimen Tracking System Industry Overview The medical specimen tracking system market size was valued at USD 739.07 million in 2021 and is estimated to grow at a compound annual growth rate (CAGR) of 10.3% from 2022 to 2030.   Favorable government regulations coupled with the rising adoption of specimen tracking systems for reducing errors in patient diagnosis are some of the key drivers of this market. According to Leica BioSystems, around 98,000 people die every year in U.S. hospitals & clinics owing to misdiagnosis. Furthermore, untapped opportunities in various emerging countries are anticipated to provide opportunities for market players to invest in the market. During the COVID-19 pandemic, the adoption of these systems increased owing to quicker as well as correct diagnosis of the samples.   Gather more insights about the market drivers, restrains and growth of the Global Medical Specimen Tracking System Market   Furthermore, their use w...